Literature DB >> 9878250

The human lamin B receptor/sterol reductase multigene family.

L Holmer1, A Pezhman, H J Worman.   

Abstract

LBR (lamin B receptor) is an integral protein of the inner nuclear membrane encoded by a gene on human chromosome 1q42.1. LBR has a nucleoplasmic, amino-terminal domain of approximately 200 amino acids followed by a carboxyl-terminal domain similar in sequence to yeast and plant sterol reductases. We have determined the primary structures of two human proteins with strong sequence similarity to the carboxyl-terminal domain of LBR and sterol reductases. Their genes have recently been assigned the symbols TM7SF2 and DHCR7. TM7SF2 mRNA is most predominantly expressed in heart and DHCR7 mRNA mostly in liver and brain. Whereas LBR is localized to the inner nuclear membrane, these two related proteins are in the endoplasmic reticulum. The TM7SF2 gene contains 10 coding exons, and its intron positions are exactly conserved in the part of the LBR gene encoding its carboxyl-terminal domain. Intron positions in the DHCR7 gene are also similar. Both of these new LBR-like genes are on chromosome 11q13. These results describe a human gene family encoding proteins of the inner nuclear membrane and endoplasmic reticulum that function in nuclear organization and/or sterol metabolism. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9878250     DOI: 10.1006/geno.1998.5615

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  39 in total

Review 1.  The inner nuclear membrane: simple, or very complex?

Authors:  S D Georgatos
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

Review 2.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

3.  Lamin B receptor regulates the growth and maturation of myeloid progenitors via its sterol reductase domain: implications for cholesterol biosynthesis in regulating myelopoiesis.

Authors:  Gayathri Subramanian; Pulkit Chaudhury; Krishnakumar Malu; Samantha Fowler; Rahul Manmode; Deepali Gotur; Monika Zwerger; David Ryan; Rita Roberti; Peter Gaines
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

Review 4.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

Review 5.  Nuclear mechanics in disease.

Authors:  Monika Zwerger; Chin Yee Ho; Jan Lammerding
Journal:  Annu Rev Biomed Eng       Date:  2011-08-15       Impact factor: 9.590

Review 6.  Diseases of the nuclear envelope.

Authors:  Howard J Worman; Cecilia Ostlund; Yuexia Wang
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

7.  FACKEL is a sterol C-14 reductase required for organized cell division and expansion in Arabidopsis embryogenesis.

Authors:  K Schrick; U Mayer; A Horrichs; C Kuhnt; C Bellini; J Dangl; J Schmidt; G Jürgens
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

8.  Dyclonine and alverine citrate enhance the cytotoxic effects of proteasome inhibitor MG132 on breast cancer cells.

Authors:  Donghong Ju; Xiaogang Wang; Youming Xie
Journal:  Int J Mol Med       Date:  2009-02       Impact factor: 4.101

9.  The lamin B receptor under transcriptional control of C/EBPepsilon is required for morphological but not functional maturation of neutrophils.

Authors:  Tatiana V Cohen; Kimberly D Klarmann; Krisada Sakchaisri; Jason P Cooper; Douglas Kuhns; Miriam Anver; Peter F Johnson; Simon C Williams; Jonathan R Keller; Colin L Stewart
Journal:  Hum Mol Genet       Date:  2008-07-11       Impact factor: 6.150

10.  Induction of a massive endoplasmic reticulum and perinuclear space expansion by expression of lamin B receptor mutants and the related sterol reductases TM7SF2 and DHCR7.

Authors:  Monika Zwerger; Thorsten Kolb; Karsten Richter; Iakowos Karakesisoglou; Harald Herrmann
Journal:  Mol Biol Cell       Date:  2009-11-25       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.